Literature DB >> 33275244

Inhibition of microRNA-346 inhibits myocardial inflammation and apoptosis after myocardial infarction via targeting NFIB.

B Yang1, R Dong, H Zhao.   

Abstract

OBJECTIVE: Acute myocardial infarction (AMI) is a sudden cardiovascular event that endangers human life. MicroRNA is considered to be an important participant in the pathophysiology of myocardial infarction (MI). This article aim was to study the function and mechanisms of microRNA-346 (miR-346) on myocardium after MI.
MATERIALS AND METHODS: To study the role of miR-346 in MI, we established H2O2-induced H9c2 cell injury model and rat MI model. Real-time polymerase chain reaction (RT-PCR) was used to detect miR-346 expression. Western blot was utilized to measure the expression of Bcl-2, Bax, TNF-α, IL-6 and NFIB. Apoptosis of H9c2 cells was detected by TUNEL staining and flow cytometry. Enzyme-linked immunosorbent assay (ELISA) assay was utilized to measure the levels of TNF-α and IL-6 in supernatant. Assessment of left ventricular function in rats was performed using echocardiography.
RESULTS: MiR-346 was significantly upregulated in H2O2-treated H9c2 cells and ischemic myocardium. In the H9c2 cell injury model, the expressions of Bax, TNF-α, and IL-6 were greatly increased while Bcl-2 expression was decreased, and the number of TUNEL-positive cells and apoptosis rate were also significantly increased. At the same time, the levels of TNF-α and IL-6 in the cell supernatant were markedly increased. However, after miR-346 expression was suppressed, these results were reversed. The expression of Bcl-2 increased, while the expression of Bax, TNF-α, and IL-6 decreased. The contents of TNF-α and IL-6 in the cell supernatant also decreased significantly. Both the number of TUNEL-positive cells and the apoptosis rate were markedly reduced. After injecting antagomir-346 into the myocardium of rats to silence miR-346, the cardiac function of MI rats was remarkably improved, and the LDH content in the serum of rats also decreased significantly. Using computational predictions tools, Western blotting and Luciferase activity assay, we found that nuclear factor I/B (NFIB) was targeted by miR-346.
CONCLUSIONS: The expression of miR-346 was increased in H9c2 cells and ischemic myocardium of MI rats. Silencing miR-346 can significantly inhibit the inflammatory response and the apoptosis of cardiomyocytes by targeting NFIB.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33275244     DOI: 10.26355/eurrev_202011_23827

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

Review 1.  Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.

Authors:  Yimeng Chen; Yichen He; Shuchen Zhao; Xiaozhou He; Dong Xue; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

2.  Transcriptional Regulation of RIP2 Gene by NFIB Is Associated with Cellular Immune and Inflammatory Response to APEC Infection.

Authors:  Hongyan Sun; Naying Li; Jishuang Tan; Huan Li; Jibin Zhang; Lujiang Qu; Susan J Lamont
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

3.  Long non-coding RNA LUCAT1 inhibits myocardial oxidative stress and apoptosis after myocardial infarction via targeting microRNA-181a-5p.

Authors:  Shi-Hui Xiao; Ying Wang; Xuecai Cao; Zhe Su
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  CircNFIC Balances Inflammation and Apoptosis by Sponging miR-30e-3p and Regulating DENND1B Expression.

Authors:  Yangfeng Chen; Zhijun Wang; Xiaolan Chen; Xi Peng; Qinghua Nie
Journal:  Genes (Basel)       Date:  2021-11-19       Impact factor: 4.096

5.  M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.

Authors:  Ashuai Du; Shiqin Li; Yuzheng Zhou; Cyrollah Disoma; Yujie Liao; Yongxing Zhang; Zongpeng Chen; Qinglong Yang; Pinjia Liu; Sixu Liu; Zijun Dong; Aroona Razzaq; Siyi Tao; Xuan Chen; Yuxin Liu; Lunan Xu; Qianjun Zhang; Shanni Li; Jian Peng; Zanxian Xia
Journal:  Mol Cancer       Date:  2022-05-06       Impact factor: 41.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.